
Cataract
Latest News
Advertisement
CME Content
Advertisement















Lens fragmentation device may avoid disrupting zonules, enhance refractive outcomes


Speaking at AAO 2019, Ashraf El Habbak MD, PhD pointed out that bevacizumab inhibits vascular endothelial growth factor, which is a potent permeability factor implicated in cystoid macular edema.






Drug combination is considered the gold standard to establish stable mydriasis during cataract surgery with lens implantation.

https://web.musc.eduWith patients seeking an easier prophylactic regimen before, after cataract surgery, a combination drop therapy used as a prophylactic treatment may provided the desired results.

Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
2
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
3
Ocular Therapeutix randomizes first patient in HELIOS-3
4
AAO 2025 Takeaways: How imaging and remote monitoring are transforming retinal care
5

















































.png)


